Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT05168566 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Sutetinib Maleate Capsule

Sponsor

Teligene US